四重复tau蛋白病患者体内tau蛋白蓄积与多巴胺缺乏相关
研究纳入38例临床诊断的四重复tau蛋白病(4R-tauopathies)患者和15例α-突触核蛋白病患者,评估[18F]PI-2620 tau-PET与[123I]-Ioflupane DaT-SPECT的相关性。在4R-tauopathies中,基底节和中脑区的[18F]PI-2620结合与纹状体DaT可用性呈负相关(苍白球内侧部和壳核β=-0.464,p=0.006)。相对tau负荷较高的DaT-SPECT结合与更好的临床表现相关(β=-0.522,p=0.011)。
要点
- 4R-tauopathies患者基底节和中脑区tau蓄积与纹状体多巴胺转运体可用性降低相关。
- α-突触核蛋白病患者中[18F]PI-2620结合与DaT可用性无显著区域关联。
- 4R-tauopathies患者维持多巴胺传递的能力可能与保留运动功能相关。
核心结论
- 在临床诊断的原发性tau蛋白病中,参与多巴胺能通路的脑区tau负荷与加重的多巴胺能功能障碍相关。
- 尽管存在tau蓄积,维持多巴胺传递的能力可能保留运动功能。
研究设计与样本
- 评估38例临床诊断的4R-tauopathies患者(21例男性;69.0±8.5岁)和15例临床诊断的α-突触核蛋白病患者(8例男性;66.1±10.3岁)。
- 患者接受[18F]PI-2620 tau-PET和[123I]-Ioflupane DaT-SPECT检查,时间间隔为3±5个月。
- 分析区域tau-PET信号与DaT可用性及其主成分在4R-tauopathies和α-突触核蛋白病患者中的相关性。
主要发现
- 在4R-tauopathies患者中,基底节和中脑区的[18F]PI-2620结合与纹状体DaT可用性呈负相关(苍白球内侧部和壳核β=-0.464,p=0.006,Durbin-Watson统计量=1.824)。
- 齿状核的[18F]PI-2620结合与纹状体DaT可用性无显著回归因子(β=0.078,p=0.662,Durbin-Watson统计量=1.686)。
- α-突触核蛋白病患者中[18F]PI-2620结合与DaT可用性无任何区域关联。
- 在4R-tauopathies患者中,相对tau负荷较高的DaT-SPECT结合与更好的临床表现相关(β=-0.522,p=0.011,Durbin-Watson统计量=2.663)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We hypothesized that severe tau burden in brain regions involved in direct or indirect pathways of the basal ganglia correlate with more severe striatal dopamine deficiency in four-repeat (4R) tauopathies. Therefore, we correlated [18F]PI-2620 tau-positron-emission-tomography (PET) imaging with [123I]-Ioflupane single-photon-emission-computed tomography (SPECT) for dopamine transporter (DaT) availability. METHODS: Thirty-eight patients with clinically diagnosed 4R-tauopathies (21 male; 69.0 ± 8.5 years) and 15 patients with clinically diagnosed α-synucleinopathies (8 male; 66.1 ± 10.3 years) who underwent [18F]PI-2620 tau-PET and DaT-SPECT imaging with a time gap of 3 ± 5 months were evaluated. Regional Tau-PET signals and DaT availability as well as their principal components were correlated in patients with 4R-tauopathies and α-synucleinopathies. Both biomarkers and the residuals of their association were correlated with clinical severity scores in 4R-tauopathies. RESULTS: In patients with 4R-tauopathies, [18F]PI-2620 binding in basal ganglia and midbrain regions was negatively associated with striatal DaT availability (i.e. globus pallidus internus and putamen (β = - 0.464, p = 0.006, Durbin-Watson statistics = 1.824) in a multiple regression model. Contrarily, [18F]PI-2620 binding in the dentate nucleus showed no significant regression factor with DaT availability in the striatum (β = 0.078, p = 0.662, Durbin-Watson statistics = 1.686). Patients with α-synucleinopathies did not indicate any regional associations between [18F]PI-2620-binding and DaT availability. Higher DaT-SPECT binding relative to tau burden was associated with better clinical performance (β = - 0.522, p = 0.011, Durbin-Watson statistics = 2.663) in patients with 4R-tauopathies. CONCLUSION: Tau burden in brain regions involved in dopaminergic pathways is associated with aggravated dopaminergic dysfunction in patients with clinically diagnosed primary tauopathies. The ability to sustain dopamine transmission despite tau accumulation may preserve motor function.
引用
- Ferschmann C, Messerschmidt K, Gnörich J, et al. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies. Eur J Nucl Med Mol Imaging. 2024. PMID: 38366196. doi:10.1007/s00259-024-06637-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。